Coeliac Disease Research Study
Starts: 01 Aug 2025
Ages: 18 - 70

Coeliac Disease Research Study

This is a research study investigating a potential new medication for Coeliac disease.
Altona North
RSV Vaccine Study
Starts: 11 Jul 2025
Ages: 18-49

RSV Vaccine Study

This is a research study looking for people between the ages of 18 to 49 investigating a new mRNA vaccine designed to prevent against Respiratory syncytial virus (RSV).
Wollongong
Cardiovascular and Kidney disease Study
Starts: 07 Jun 2024
Ages: 45+

Cardiovascular and Kidney disease Study

This study is researching the effects of a medication on the cardiovascular outcomes and kidney function in adults living with obesity. Living with excess weight or obesity can increase your risk of chronic health conditions, such as cardiovascular disease and kidney disease.  
Northern Beaches
Expressions of Interest: Respiratory virus vaccine research program
Starts: 18 Jun 2025
Ages: 18 - 45

Expressions of Interest: Respiratory virus vaccine research program

Canopy Clinical Wollongong has launched a new respiratory virus vaccine research program for local Illawarra residents between the ages of 18 and 45.
Wollongong
Influenza Vaccine Study
Starts: 09 Jun 2025
Ages: 65+

Influenza Vaccine Study

This study is researching an investigational influenza vaccine for people aged 65 and older. The vaccine aims to be more effective in preventing influenza A and B in comparison to current publicly available influenza vaccines.
Northern Beaches
Wollongong
Hypertriglyceridemia Study
Starts: 02 Jun 2025
Ages: 18 - 70

Hypertriglyceridemia Study

This study is investigating the effect of a potential new medication designed to lower triglyceride levels in people with hypertriglyceridemia.
Altona North
Chronic heart disease – Atherosclerosis study
Starts: 01 May 2025
Ages: 18+

Chronic heart disease - Atherosclerosis study

This is a research study investigating a potential new treatment for atherosclerosis, a chronic heart disease.
Altona North
Venous Leg Ulcers Study
Starts: 01 Mar 2025
Ages: 18+

Venous Leg Ulcers Study

This research study is investigating a new potential treatment for Venous Leg Ulcers (VLUs), a clear gel containing an experimental drug that is applied directly to the VLU; compared to a control placebo gel treatment.
Altona North
Wollongong
Panic disorder study
Starts: 01 Feb 2025
Ages: 18+

Panic disorder study

This study is investigating the use of a new medication that is a combination of two previously approved treatments for hypertension to target the CNS physiological stress system for patients with panic disorder.
Sutherland Shire
Wollongong
Genital Herpes Study
Starts: 01 Feb 2025
Ages: 18 - 60

Genital Herpes Study

This research study is investigating the safety and effects of a new antiviral medication to suppress recurrent genital herpes in participants living with recurrent genital herpes.
Wollongong
Northern Beaches
Sutherland Shire
Weight Management Research Program
Starts: 17 Apr 2025
Ages: 18+

Weight Management Research Program

Canopy Clinical has launched a suite of weight-management related studies. Register your interest in participating today.
Wollongong
Altona North
Sutherland Shire
Northern Beaches
Atopic Dermatitis Study
Starts: 02 Apr 2025
Ages: 18+

Atopic Dermatitis Study

This study is testing a new potential topical treatment for atopic dermatitis (AD), a long-term skin condition that causes intense itching, redness, and irritation.
Northern Beaches
Wollongong
Altona North

No studies found

Please try again with different filters.

Clear Filters

Not eligible for these studies?

Don’t worry—eligibility criteria vary, and new clinical trials are always on the horizon. By registering your interest, we can get in touch when a study comes up that better suits your profile. It’s a simple way to stay connected with opportunities that may benefit you.

Testimonials

“I participated in the trial to help everyone to develop a combined safe vaccine. I would definitely recommend the trials to anyone. The staff were all friendly and efficient!”
Deidre
Deidre
Two Trials Completed in 2023 and 2024
“Positive and welcoming and experience from staff! Really made us feel like we were making a difference, especially during the age of COVID.”
Elizabeth
Elizabeth
Three-time Trial Participant
“I'm participating in the trial to progress research and for better and more effective vaccinations for the future. The staff are very friendly and professional!”
Kim
Kim
2022 COVID-19 Vaccine Trial Participant